Prescriber's Corner
Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
Vivian Tsang, PharmD, BCOP
From Cedars-Sinai Medical Center, Los Angeles, California
The author has no conflicts of interest to disclose.
Correspondence to: Vivian Tsang, PharmD, BCOP, Cedars-Sinai Medical Center, 8700 Beverley Boulevard, Los Angeles, CA 90048. E-mail: tsangv@cshs.org
J Adv Pract Oncol 2012;3:184–190 |
DOI: 10.6004/jadpro.2012.3.3.8 |
© 2012 Harborside Press®
For access to the full length article, please
sign in.
